Abstract: An editing apparatus includes an editing unit configured to edit an additional information file related to a moving image file, and a control unit configured to perform control so as not to permit editing of the additional information file in a case where the additional information file is a file requiring repair processing or the moving image file related to the additional information file is a file requiring the repair processing.

Abstract: An editing apparatus includes an editing unit configured to edit an additional information file related to a moving image file, and a control unit configured to perform control so as not to permit editing of the additional information file in a case where the additional information file is a file requiring repair processing or the moving image file related to the additional information file is a file requiring the repair processing.

Abstract: An audio processing apparatus includes an audio file recovery unit configured to recover an audio file related to a video file. With video data of the video file and audio data of the audio file recorded at different speed rates from each other, the audio file recovery unit recovers the audio file so that an end position of the audio data coincides with an end position of the video data in playback of the audio data and the video data at a speed rate.

Abstract: An audio processing apparatus includes an audio file recovery unit configured to recover an audio file related to a video file. With video data of the video file and audio data of the audio file recorded at different speed rates from each other, the audio file recovery unit recovers the audio file so that an end position of the audio data coincides with an end position of the video data in playback of the audio data and the video data at a speed rate.

Abstract: An image recording apparatus can record an appropriate reel number and an appropriate camera identification (ID) in a volume label of a recording medium even in a case where a management file is generated for each moving image format. In a case where a management file of a first moving image format set as a recording format of a moving image file is not recorded, and a management file of another moving image format is recorded in a recording medium, the image recording apparatus determines a reel number of the recording medium based on information about the reel number included in the management file of the another moving image format and records the management file of the first moving image format including the information about the determined reel number in the recording medium, and does not update or record the volume label in the recording medium.

Abstract: An image recording apparatus can record an appropriate reel number and an appropriate camera identification (ID) in a volume label of a recording medium even in a case where a management file is generated for each moving image format. In a case where a management file of a first moving image format set as a recording format of a moving image file is not recorded, and a management file of another moving image format is recorded in a recording medium, the image recording apparatus determines a reel number of the recording medium based on information about the reel number included in the management file of the another moving image format and records the management file of the first moving image format including the information about the determined reel number in the recording medium, and does not update or record the volume label in the recording medium.

Abstract: The present invention provides a transgenic non-human mammal retaining, in a specifically expressible state, a DNA encoding IL-33 in the skin, and having one or more features selected from the group consisting of (1) spontaneous onset of dermatitis, (2) increase in the number of inflammatory cells, (3) increase in total IgE concentration, histamine concentration, cytokine concentration and/or chemokine concentration, and (4) increase in scratching time, under SPF (specific pathogen free) breeding conditions, as compared to a corresponding non-transgenic non-human mammal, and the like.

Abstract: The present invention provides a transgenic non-human mammal retaining, in a specifically expressible state, a DNA encoding IL-33 in the skin, and having one or more features selected from the group consisting of (1) spontaneous onset of dermatitis, (2) increase in the number of inflammatory cells, (3) increase in total IgE concentration, histamine concentration, cytokine concentration and/or chemokine concentration, and (4) increase in scratching time, under SPF (specific pathogen free) breeding conditions, as compared to a corresponding non-transgenic non-human mammal, and the like.

Abstract: [Problems] The objective is to provide a new low-toxic drug for external use for intractable diseases, such as erosion, decubitus, and skin ulcer, that prevents cicatrization and reduces iodine accumulation on wound surfaces with sufficiently promoting healing. [Means for solving problem] Preparation of a wound treatment drug for external use containing oily bases and iodine but substantially no white soft sugar, which is a characteristic of the drug of this invention. The invented drug prevents infection through the wound surface due to a sufficient bactericidal effect of iodine, and promotes wound healing, prevents cicatrization and reduces iodine accumulation on the wound surface by maintenance of appropriate moisture in the wound surface due to a moisturizing effect of oily bases.

Abstract: The present invention provides methods which use induction phenomenon of production of interleukin 18 (IL-18) from keratinocyte (KC), and their usages. The methods are preferably applicable for understanding of pathogenic mechanisms of atopic dermatitis (AD) and AD-like symptoms, and for development of therapeutic drugs for AD and AD-like symptoms. For example, by applying, on skin of mice or the like, protein A (SpA) derived from Staphylococcus aureus, or transplanting, on mice, a skin graft which has developed an inflammatory skin disease like AD, it is possible to reproduce elevation of IgE to high level in serum, which elevation is generated in an AD-like lesion. As a result, it is possible, for example, to screen for an inhibitor which inhibits induction of production of IL-18 from KC.

Abstract: The execution of a process is analyzed by a data processing method using a data analysis device for processing a job by combining the processes of transforming input data and generating output data. The execution history of the process is recorded, and each time the process is executed, it is determined whether the process execution has a high anomaly probability based on a predetermined determination indicator. Upon determining that the process execution has a high anomaly probability, the process log information of the process including the determination indicator is recorded, and based on the process log information and the process execution history, the process with the high anomaly probability is further analyzed. By determining whether the process is anomalous or not, the process history analysis information including the analysis result and the execution history of the process to be analyzed is generated.

Abstract: It is judged whether the reference data is the latest and if not the latest, the data is updated to the latest in a short time. A program in which data creation procedure is pre-defined creates requested secondary data according to primary data. The primary data, the secondary data, and data update information including the primary data update time and the secondary data update time are stored in a storage device. When the relationship between data update information on the primary data and the secondary data used for creating the requested secondary data when generation of the secondary data is requested and the data update information on the requested secondary data does not satisfy a predetermined condition, a program for creating the requested secondary data is executed. Furthermore, the primary data and the secondary data are outputted to the output unit while correlating them to each other.

Abstract: The present invention provides methods which use induction phenomenon of production of interleukin 18 (IL-18) from keratinocyte (KC), and their usages. The methods are preferably applicable for understanding of pathogenic mechanisms of atopic dermatitis (AD) and AD-like symptoms, and for development of therapeutic drugs for AD and AD-like symptoms. For example, by applying, on skin of mice or the like, protein A (SpA) derived from Staphylococcus aureus, or transplanting, on mice, a skin graft which has developed an inflammatory skin disease like AD, it is possible to reproduce elevation of IgE to high level in serum, which elevation is generated in an AD-like lesion. As a result, it is possible, for example, to screen for an inhibitor which inhibits induction of production of IL-18 from KC.

Abstract: The ? antigen-encoding gene and the ? antigen protein suppress the production of interleukin-4 etc., improve the Th2 type cytokine-dominant state, and furthermore inhibit various conditions of allergic diseases such as IgE production, histamine release and eosinophil infiltration, and therefore they are very effective for the prevention or treatment of atopic diseases such as atopic dermatitis, asthma, allergic rhinitis, and allergic conjunctivitis, and more broadly allergic diseases.

Abstract: The ? antigen-encoding gene and the ? antigen protein suppress the production of interleukin-4 etc., improve the Th2 type cytokine-dominant state, and furthermore inhibit various conditions of allergic diseases such as IgE production, histamine release and eosinophil infiltration, and therefore they are very effective for the prevention or treatment of atopic diseases such as atopic dermatitis, asthma, allergic rhinitis, and allergic conjunctivitis, and more broadly allergic diseases.

Abstract: Thinning of a planar illumination device using LEDS is accelerated while higher and more uniform brightness is promoted. A planar illumination device 10 according to the present invention comprises a light guide plate 2, LEDs 21 to 23 arranged on a side end face 3 of the light guide plate 2, and an FPC 11 on which the LEDs 21 to 23 are mounted. The LEDs 21 to 23 have exposed light emitting portions 21a to 23a made of a translucent resin that seals LED chips mounted on the FPC 11 with the light-emitting portions 21a to 23a projecting from an outline of the FPC 11 and arranged so that the light-emitting portions 21a to 23a are not projected from the side end face 3 of the light guide plate 2. Further, the planar illumination device has reflecting means 25 covering the light-emitting portions 21a to 23a.

Abstract: The ? antigen-encoding gene and the ? antigen protein suppress the production of interleukin-4 etc., improve the Th2 type cytokine-dominant state, and furthermore inhibit various conditions of allergic diseases such as IgE production, histamine release and eosinophil infiltration, and therefore they are very effective for the prevention or treatment of atopic diseases such as atopic dermatitis, asthma, allergic rhinitis, and allergic conjunctivitis, and more broadly allergic diseases.

Abstract: [Problems] The objective is to provide a new low-toxic drug for external use for intractable diseases, such as erosion, decubitus, and skin ulcer, that prevents cicatrization and reduces iodine accumulation on wound surfaces with sufficiently promoting healing. [Means for solving problem] Preparation of a wound treatment drug for external use containing oily bases and iodine but substantially no white soft sugar, which is a characteristic of the drug of this invention. The invented drug prevents infection through the wound surface due to a sufficient bactericidal effect of iodine, and promotes wound healing, prevents cicatrization and reduces iodine accumulation on the wound surface by maintenance of appropriate moisture in the wound surface due to a moisturizing effect of oily bases.

Abstract: A planar lighting apparatus is provided in which thinning is promoted while higher and more uniform brightness is achieved by maintaining an LED on a light-incoming face of a light guide plate easily and stably. A planar lighting apparatus 10 according to the present invention is provided with a light guide plate 2 and an LED 11 arranged on a light-incoming face 3 of the light guide plate 2. The light guide plate 2 has a pressing portion 5 formed integrally with the light guide plate 2 and opposite to the light-incoming face 3 with a predetermined gap d, and the LED 11 is held between the pressing portion 5 and the light-incoming face 3 and brought into pressure contact with the light-incoming face 3 by an elastic action of the pressing portion 5 so as to maintain the position and attitude with respect to the light guide plate 2 properly and stably.

Abstract: The curvature of a circular arc constituted by a side of a suction groove is made larger than that of a circular arc constituted by a side of a discharge groove. Thus, when the suction groove and the discharge groove are viewed in the axial direction of a drive shaft, the distance between the suction groove and the discharge groove in the radial direction of a rotary portion is short in a region intersecting with a line W perpendicular to a centerline, and increases in accordance with a decrease in distance from containment portions. It is therefore possible to ensure a sufficient distance between the discharge and suction grooves and enhance a total fluid pressure generated therebetween, and the contact surface pressure that is necessitated by a second side plate to obtain a press-back force when being in contact with an outer rotor and an inner rotor is reduced.